Henry N Ginsberg

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 22

Top Venues

Arteriosclerosis, thrombosis, and vascular biology

Circulation research

Diabetes

European heart journal

Columbia University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Columbia University Jul 01 1985

United States

Professor of Medicine :: Medicine

Publications

Willemien van Zwol, Bart van de Sluis, Henry N Ginsberg, Jan Albert Kuivenhoven
VLDL Biogenesis and Secretion: It Takes a Village. Circulation research 134 (2) (2024)
Willemien van Zwol, Bart van de Sluis, Henry N Ginsberg, Jan Albert Kuivenhoven
VLDL Biogenesis and Secretion: It Takes a Village. Circulation research 134 (2) (2024)
Gissette Reyes-Soffer, Anastasiya Matveyenko, James Lignos, Nelsa Matienzo, Leinys S Santos-Báez, Antonio Hernandez-Ono, Lau Yung, Renu Nandakumar, Sasha A Singh, Masanori Aikawa, Richard T George, Henry N Ginsberg
Effects of Recombinant Human Lecithin Cholesterol Acyltransferase on Lipoprotein Metabolism in Humans. Arteriosclerosis, thrombosis, and vascular biology 44 (6) (2024)
Willemien van Zwol, Bart van de Sluis, Henry N Ginsberg, Jan Albert Kuivenhoven
VLDL Biogenesis and Secretion: It Takes a Village. Circulation research 134 (2) (2024)
Gissette Reyes-Soffer, Anastasiya Matveyenko, James Lignos, Nelsa Matienzo, Leinys S Santos-Báez, Antonio Hernandez-Ono, Lau Yung, Renu Nandakumar, Sasha A Singh, Masanori Aikawa, Richard T George, Henry N Ginsberg
Effects of Recombinant Human Lecithin Cholesterol Acyltransferase on Lipoprotein Metabolism in Humans. Arteriosclerosis, thrombosis, and vascular biology (2024)
Willemien van Zwol, Bart van de Sluis, Henry N Ginsberg, Jan Albert Kuivenhoven
VLDL Biogenesis and Secretion: It Takes a Village. Circulation research 134 (2) (2024)
Willemien van Zwol, Bart van de Sluis, Henry N Ginsberg, Jan Albert Kuivenhoven
VLDL Biogenesis and Secretion: It Takes a Village. Circulation research 134 (2) (2024)
Gissette Reyes-Soffer, Anastasiya Matveyenko, James Lignos, Nelsa Matienzo, Leinys S Santos-Báez, Antonio Hernandez-Ono, Lau Yung, Renu Nandakumar, Sasha A Singh, Masanori Aikawa, Richard T George, Henry N Ginsberg
Effects of Recombinant Human Lecithin Cholesterol Acyltransferase on Lipoprotein Metabolism in Humans. Arteriosclerosis, thrombosis, and vascular biology 44 (6) (2024)
Willemien van Zwol, Bart van de Sluis, Henry N Ginsberg, Jan Albert Kuivenhoven
VLDL Biogenesis and Secretion: It Takes a Village. Circulation research 134 (2) (2024)
Wen Dai, Heng Zhang, Hayley Lund, Ziyu Zhang, Mark Castleberry, Maya Rodriguez, George Kuriakose, Sweta Gupta, Magdalena Lewandowska, Hayley R Powers, Swati Valmiki, Jieqing Zhu, Amy D Shapiro, M Mahmood Hussain, José A López, Mary G Sorci-Thomas, Roy L Silverstein, Henry N Ginsberg, Daisy Sahoo, Ira Tabas, Ze Zheng
Intracellular tPA-PAI-1 interaction determines VLDL assembly in hepatocytes. Science (New York, N.Y.) 381 (6661) (2023)
Rachel A Warren, Allie S Carew, Pantelis Andreou, Andrew P Levy, John L Sapp, Orit Lache, Henry N Ginsberg, Eric Bruce Rimm, Christine Herman, Susan Kirkland, Leah E Cahill
Relationship Between Time-Varying Achieved High-Density Lipoprotein Cholesterol and Risk of Coronary Events Depends on Haptoglobin Phenotype Within the ACCORD Lipid Study. Journal of the American Heart Association (2023)
Antonio Hernandez-Ono, Yi Peng Zhao, John W Murray, Cecilia Östlund, Michael J Lee, Angsi Shi, William T Dauer, Howard J Worman, Henry N Ginsberg, Ji-Yeon Shin
Functional interaction of torsinA and its activators in liver lipid metabolism. bioRxiv : the preprint server for biology (2023)
Henry N Ginsberg, Ira J Goldberg
Broadening the Scope of Dyslipidemia Therapy by Targeting APOC3 (Apolipoprotein C3) and ANGPTL3 (Angiopoietin-Like Protein 3). Arteriosclerosis, thrombosis, and vascular biology 43 (3) (2022)
Henry N Ginsberg, Ira J Goldberg
Broadening the Scope of Dyslipidemia Therapy by Targeting APOC3 and ANGPTL3 (Angiopoietin-Like Protein 3). Arteriosclerosis, thrombosis, and vascular biology (2022)
Sadberk Lale Tokgözoğlu, Carl E Orringer, Henry N Ginsberg, Alberico Luigi Catapano
The year in cardiovascular medicine 2021: dyslipidaemia. European heart journal 43 (8) (2022)
Henry N Ginsberg, Ira J Goldberg
Broadening the Scope of Dyslipidemia Therapy by Targeting APOC3 (Apolipoprotein C3) and ANGPTL3 (Angiopoietin-Like Protein 3). Arteriosclerosis, thrombosis, and vascular biology 43 (3) (2022)
Henry N Ginsberg, Ira J Goldberg
Broadening the Scope of Dyslipidemia Therapy by Targeting APOC3 and ANGPTL3 (Angiopoietin-Like Protein 3). Arteriosclerosis, thrombosis, and vascular biology (2022)
Henry N Ginsberg, Ira J Goldberg
Broadening the Scope of Dyslipidemia Therapy by Targeting APOC3 (Apolipoprotein C3) and ANGPTL3 (Angiopoietin-Like Protein 3). Arteriosclerosis, thrombosis, and vascular biology 43 (3) (2022)
Henry N Ginsberg, Ira J Goldberg
Broadening the Scope of Dyslipidemia Therapy by Targeting APOC3 (Apolipoprotein C3) and ANGPTL3 (Angiopoietin-Like Protein 3). Arteriosclerosis, thrombosis, and vascular biology 43 (3) (2022)
Søren S Lund, Naveed Sattar, Afshin Salsali, Dietmar Neubacher, Henry N Ginsberg
Potential contribution of haemoconcentration to changes in lipid variables with empagliflozin in patients with type 2 diabetes: A post hoc analysis of pooled data from four phase 3 randomized clinical trials. Diabetes, obesity & metabolism 23 (12) (2021)
Alan Chait, Henry N Ginsberg, Tomas Vaisar, Jay W Heinecke, Ira J Goldberg, Karin E Bornfeldt
Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease. Diabetes 69 (4) (2020)
Mario Luca Morieri, Hetal S Shah, Jennifer Sjaarda, Petra A Lenzini, Hannah Campbell, Allison A Motsinger-Reif, He Gao, Laura Lovato, Sabrina Prudente, Assunta Pandolfi, Marcus G Pezzolesi, Ronald J Sigal, Guillaume Paré, Santica M Marcovina, Daniel M Rotroff, Elisabetta Patorno, Luana Mercuri, Vincenzo Trischitta, Emily Y Chew, Peter Kraft, John B Buse, Michael J Wagner, Sharon Cresci, Ulagamadesan Venkatesan, Henry N Ginsberg, Josyf C Mychaleckyj, Alessandro Doria
PPARA Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-Lipid. Diabetes 69 (4) (2020)

Henry N Ginsberg.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Henry N Ginsberg